Barden Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $848K | Sell |
2,180
-47
| -2% | -$18.3K | 0.74% | 47 |
|
|
2025
Q1 | $969K | Buy |
2,227
+91
| +4% | +$39.6K | 0.86% | 47 |
|
|
2024
Q4 | $788K | Sell |
2,136
-2,115
| -50% | -$780K | 0.68% | 52 |
|
|
2024
Q3 | $2.21M | Buy |
4,251
+98
| +2% | +$51K | 1.94% | 17 |
|
|
2024
Q2 | $2.25M | Buy |
4,153
+25
| +0.6% | +$13.5K | 2.12% | 16 |
|
|
2024
Q1 | $2.14M | Sell |
4,128
-5,774
| -58% | -$2.99M | 2.07% | 16 |
|
|
2023
Q4 | $4.36M | Buy |
9,902
+5,658
| +133% | +$2.49M | 3.55% | 5 |
|
|
2023
Q3 | $1.85M | Buy |
4,244
+355
| +9% | +$154K | 1.8% | 17 |
|
|
2023
Q2 | $1.73M | Sell |
3,889
-299
| -7% | -$133K | 1.9% | 13 |
|
|
2023
Q1 | $1.93M | Sell |
4,188
-74
| -2% | -$34K | 1.84% | 18 |
|
|
2022
Q4 | $2.18M | Buy |
4,262
+274
| +7% | +$140K | 2.23% | 10 |
|
|
2022
Q3 | $1.81M | Buy |
3,988
+59
| +2% | +$26.8K | 2.11% | 11 |
|
|
2022
Q2 | $1.9M | Sell |
3,929
-390
| -9% | -$188K | 2.06% | 14 |
|
|
2022
Q1 | $2.12M | Sell |
4,319
-327
| -7% | -$161K | 2.08% | 12 |
|
|
2021
Q4 | $2.15M | Buy |
+4,646
| New | +$2.15M | 2.05% | 14 |
|